An Approach to Apply BDNF Targeting Fe 3 O 4 -Based Nanoparticles as Multifunctional Anti-Alzheimer Agents.
Lei FangYunxia SongHaifeng JinYinyin LiuShaohua GouPublished in: Small (Weinheim an der Bergstrasse, Germany) (2024)
To search for novel anti-Alzheimer agents, multifunctional Fe 3 O 4 -based nanoparticles (FSSIO) is designed and prepared which contain ferulic acid (FA) and Simvastatin linked to the surface of Fe 3 O 4 particles. In vitro tests confirmed that FSSIO possessed favorable biocompatibility and a pronounced ability to penetrate blood brain barrier. The FA moiety endowed the particles with remarkable antioxidant and anti-inflammatory properties, and effectively protected neuron cells from the toxicity induced by Aβ. Moreover, the Simvastatin pharmacophore assists the particles up-regulate the expression level of BDNF and significantly promotes the expression levels of p-TrkB, p-ERK, p-PI3K and Akt, which consequently leads to the neurite outgrowth via regulating PI3K/ATK and TrkB-mediated signaling pathway. More importantly, in the Morris water maze test, FSSIO shows excellent activity to enhance the learning and memory retention of AD model rats.
Keyphrases
- signaling pathway
- blood brain barrier
- anti inflammatory
- poor prognosis
- cancer therapy
- pi k akt
- drug delivery
- cognitive decline
- oxidative stress
- cell proliferation
- epithelial mesenchymal transition
- stress induced
- induced apoptosis
- cerebral ischemia
- molecular dynamics
- long non coding rna
- molecular docking
- binding protein